• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管进行了预防治疗,仍通过磁共振成像在患有 A 或 B 型血友病的临床无症状关节中识别和长期观察早期关节损伤。

Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis.

机构信息

Department of Pediatric Hemostaseology, Pediatric Hemophilia Center, Dr. von Hauner's Children's Hospital, University of Munich, Munich, Germany.

出版信息

Haemophilia. 2012 May;18(3):369-74. doi: 10.1111/j.1365-2516.2011.02682.x. Epub 2011 Oct 28.

DOI:10.1111/j.1365-2516.2011.02682.x
PMID:22032268
Abstract

Severe haemophilia is associated with recurrent joint bleeds, which can lead to haemophilic arthropathy. Subclinical joint bleeds have also been associated with joint damage detected using magnetic resonance imaging (MRI). We investigated the development of early changes in clinically asymptomatic joints using MRI in haemophilia A or B patients receiving prophylactic therapy. In this single-centre retrospective cohort study, patients with clinical evidence of joint damage in one ankle and one clinically asymptomatic ankle, in which we performed an MRI scan of both ankles in one session, were enrolled. MRI findings were graded using a 4-point scoring system (0 = normal findings and III = severe joint damage). Since 2000, 38 MRIs in 26 patients have been performed. Starting at a median age of 4 years, 23 patients received prophylaxis 2-3 times weekly. On-demand treatment was performed in three patients. Eight patients (31%) presented with an MRI score of 0, 12 (46%) had a score of I, four (15%) had a score of II, and two (8%) had a score of III in the clinically unaffected ankle. The six patients with MRI scores of II and III had started regular prophylaxis between the ages of 2 years and 15 years; none had developed an inhibitor or experienced a clinically evident bleed in the asymptomatic ankle. During our study, five of 26 patients had a worsening of MRI findings without experiencing a joint bleed. Early morphological changes in clinically asymptomatic ankles can be detected using MRI, despite adequate prophylaxis.

摘要

重度血友病与反复关节出血有关,这可能导致血友病性关节病。亚临床关节出血也与磁共振成像(MRI)检测到的关节损伤有关。我们研究了接受预防性治疗的 A 型或 B 型血友病患者无症状关节的早期变化。在这项单中心回顾性队列研究中,招募了有一个踝关节临床关节损伤和一个临床无症状踝关节的患者,我们在一次检查中对两个踝关节进行了 MRI 扫描。使用 4 分制评分系统(0 = 正常发现和 III = 严重关节损伤)对 MRI 结果进行分级。自 2000 年以来,对 26 名患者的 38 次 MRI 进行了评估。23 名患者从 4 岁中位数开始每周接受 2-3 次预防性治疗。有 3 名患者按需治疗。在临床未受影响的踝关节中,8 名患者(31%)MRI 评分为 0,12 名患者(46%)评分为 I,4 名患者(15%)评分为 II,2 名患者(8%)评分为 III。MRI 评分为 II 和 III 的 6 名患者在 2 至 15 岁之间开始定期接受预防性治疗;在无症状踝关节中,他们均未出现抑制剂或明显出血。在我们的研究期间,26 名患者中有 5 名患者尽管接受了充分的预防治疗,但 MRI 检查结果仍恶化。尽管进行了充分的预防治疗,仍可以通过 MRI 检测到无症状踝关节的早期形态变化。

相似文献

1
Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis.尽管进行了预防治疗,仍通过磁共振成像在患有 A 或 B 型血友病的临床无症状关节中识别和长期观察早期关节损伤。
Haemophilia. 2012 May;18(3):369-74. doi: 10.1111/j.1365-2516.2011.02682.x. Epub 2011 Oct 28.
2
[Prevention of joint damage in hemophilic children with early prophylaxis].[早期预防对血友病患儿关节损伤的预防作用]
Orthopade. 1999 Apr;28(4):341-6. doi: 10.1007/PL00003616.
3
MRI scores of ankle joints in children with haemophilia--comparison with clinical data.血友病患儿踝关节的MRI评分——与临床数据的比较
Haemophilia. 2005 Mar;11(2):116-22. doi: 10.1111/j.1365-2516.2005.01061.x.
4
Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed.重度血友病临床表型的变异性:首次关节出血的作用。
Haemophilia. 2005 Sep;11(5):438-43. doi: 10.1111/j.1365-2516.2005.01124.x.
5
Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania.立陶宛间歇性治疗重度 A 型和 B 型血友病男童的 Haemophilia Joint Health Score 的应用。
Haemophilia. 2010 May;16(3):479-86. doi: 10.1111/j.1365-2516.2009.02178.x. Epub 2010 Jan 12.
6
When should prophylactic treatment in patients with haemophilia A and B start?--The German experience.血友病A和B患者的预防性治疗应何时开始?——德国的经验。
Haemophilia. 1998 Jul;4(4):413-7. doi: 10.1046/j.1365-2516.1998.440413.x.
7
Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.重度血友病的预防:有无抑制物情况下的临床挑战
Haemophilia. 2008 Jul;14 Suppl 3:196-201. doi: 10.1111/j.1365-2516.2008.01736.x.
8
Progression of haemophilic arthropathy in children: a Lithuanian--Danish comparative study.儿童血友病性关节病的进展:立陶宛-丹麦的比较研究。
Haemophilia. 2013 Mar;19(2):212-8. doi: 10.1111/hae.12058. Epub 2012 Nov 20.
9
[Prophylactic treatment with clotting factor to prevent joint damage in patients with severe haemophilia: costs versus benefits].[使用凝血因子进行预防性治疗以预防重度血友病患者关节损伤:成本与效益]
Ned Tijdschr Geneeskd. 2007 Nov 24;151(47):2606-8.
10
Comparison of ultrasound and magnetic resonance imaging for diagnosis and follow-up of joint lesions in patients with haemophilia.超声与磁共振成像在血友病患者关节病变诊断及随访中的对比研究。
Haemophilia. 2014 Jan;20(1):e51-7. doi: 10.1111/hae.12268. Epub 2013 Sep 24.

引用本文的文献

1
Prospective, Observational Study of the Clinical Outcomes of FVIII Treatment in Adults and Adolescents with Severe Haemophilia A.成人和青少年重度A型血友病患者FVIII治疗临床结局的前瞻性观察研究
TH Open. 2025 Jun 17;9:a26219749. doi: 10.1055/a-2621-9749. eCollection 2025.
2
Global trends in hemophilic arthropathy research: a bibliometric and visualization analysis.血友病性关节病研究的全球趋势:文献计量与可视化分析
Front Med (Lausanne). 2025 Apr 16;12:1556906. doi: 10.3389/fmed.2025.1556906. eCollection 2025.
3
Treatment of Bleeding Episodes With Efanesoctocog Alfa in Previously Treated Patients With Severe Hemophilia A in the Phase 3 XTEND-1 Study.
在3期XTEND-1研究中,使用阿法依那索单抗治疗既往接受过治疗的重度A型血友病患者的出血发作情况。
Am J Hematol. 2025 May;100(5):813-820. doi: 10.1002/ajh.27603. Epub 2025 Feb 10.
4
Effectiveness of PK-Guided Personalized Recombinant FVIII Treatment in Patients with Hemophilia A: Clinical Case Experiences Based on an Observational Study.PK 指导的个性化重组 FVIII 治疗在甲型血友病患者中的有效性:基于一项观察性研究的临床病例经验
J Blood Med. 2025 Jan 10;16:27-39. doi: 10.2147/JBM.S479564. eCollection 2025.
5
Efanesoctocog Alfa versus Standard and Extended Half-Life Factor VIII Prophylaxis in Adolescent and Adult Patients with Haemophilia A without Inhibitors.依费奈索托考格阿尔法与标准及延长半衰期因子VIII预防治疗对无抑制物的青少年和成年甲型血友病患者的疗效比较
Adv Ther. 2025 Jan;42(1):427-441. doi: 10.1007/s12325-024-03032-3. Epub 2024 Nov 22.
6
MR Imaging of Hemosiderin Deposition in the Ankle Joints of Patients with Haemophilia: The Contribution of a Multi-Echo Gradient-Echo Sequence-Correlation with Osteochondral Changes and the Number and Chronicity of Joint Bleeds.血友病患者踝关节含铁血黄素沉积的磁共振成像:多回波梯度回波序列的作用——与骨软骨改变以及关节出血次数和慢性程度的相关性
Life (Basel). 2024 Sep 4;14(9):1112. doi: 10.3390/life14091112.
7
Aberrant methylation and expression of TNXB promote chondrocyte apoptosis and extracullar matrix degradation in hemophilic arthropathy via AKT signaling.异常的 TNXB 甲基化和表达通过 AKT 信号促进血友病性关节炎中的软骨细胞凋亡和细胞外基质降解。
Elife. 2024 May 31;13:RP93087. doi: 10.7554/eLife.93087.
8
Pharmacokinetics of recombinant factor VIII in adults with severe hemophilia A: fixed-sequence single-dose study of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa.重组凝血因子VIII在重度A型血友病成人患者中的药代动力学:八因子、聚乙二醇化重组凝血因子VIII和重组凝血因子VIII的固定顺序单剂量研究
Res Pract Thromb Haemost. 2023 May 13;7(4):100176. doi: 10.1016/j.rpth.2023.100176. eCollection 2023 May.
9
The Arrival of Gene Therapy for Patients with Hemophilia A.基因治疗血友病 A 患者时代的到来。
Int J Mol Sci. 2022 Sep 6;23(18):10228. doi: 10.3390/ijms231810228.
10
International consensus recommendations on the management of people with haemophilia B.关于B型血友病患者管理的国际共识建议。
Ther Adv Hematol. 2022 Apr 2;13:20406207221085202. doi: 10.1177/20406207221085202. eCollection 2022.